Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series.
Smith JL, Menzies AM, Cohen JV, Mut-Lloret M, Ozgun A, Spain L, Park J, Quach HT, Pallan L, McQuade J, Feng S, Sandhu S, Atkinson V, Tsai K, Long GV, Larkin J, Eroglu Z, Johnson DB, Sullivan R, Herkes GK, Henderson A, Carlino MS.
Smith JL, et al. Among authors: herkes gk.
Melanoma Res. 2022 Dec 1;32(6):451-459. doi: 10.1097/CMR.0000000000000825. Epub 2022 Sep 23.
Melanoma Res. 2022.
PMID: 36164923